Adimab Inc - NH Grafton, Lebanon 03766

Adimab Inc entered the industry of Biotechnology Products and Services in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417114, which describes it as a Biotechnology Products and Services. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biotechnology Products and Services. The business provides service to the B2B market.

To acquire more information, please contact Tillman Gerngross, Chief Executive Officer by calling (603) 727-7107 during business hours. You can also write to the business’ Single Location at 16 Cavendish Court, Lebanon, New Hampshire NH 03766. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Adimab Inc
Representative: Tillman Gerngross, Chief Executive Officer
Place of Business: 16 Cavendish Court, Lebanon, NH 03766
Contact Number: (603) 727-7107
Type of Service: Biotechnology Products and Services
SIC Number: 8731
NAICS Number: 5417114
Locality: Single Location
Market Type: B2B (Business to Business)
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Adimab Inc is a company operating from Grafton, New Hampshire providing professional Biotechnology Products and Services and relevant B2B variables. It was founded in 0 and registered with the SIC code 8731 as Biotechnology Products and Services, and with the NAICS code 5417114 as Biotechnology Products and Services.

With a current employee count of 1 to 4, Adimab Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Tillman Gerngross, Chief Executive Officer at (603) 727-7107 for related queries, or to locate its Single Location using the coordinates 43.67902,-72.25924.

The Single Location can also be found at the street address 16 Cavendish Court in Lebanon, New Hampshire 03766 and can be engaged online through the company website at , the company Twitter , and Facebook page .